Exelixis
EXEL
#1759
Rank
A$16.96 B
Marketcap
A$63.01
Share price
-0.71%
Change (1 day)
15.34%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company